{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T22:06:27Z","timestamp":1748469987329,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T00:00:00Z","timestamp":1514851200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00417-017-3864-x","type":"journal-article","created":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T22:42:42Z","timestamp":1514932962000},"page":"989-995","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Conjunctival melanoma: association of cyclooxygenase-2 tumor expression to prognosis"],"prefix":"10.1007","volume":"256","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1767-8080","authenticated-orcid":false,"given":"Rita","family":"Pinto-Proen\u00e7a","sequence":"first","affiliation":[]},{"given":"Mariana","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Cristina","family":"Fonseca","sequence":"additional","affiliation":[]},{"given":"J\u00falia","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Maria Filomena","family":"Gaspar","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Proen\u00e7a","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,1,2]]},"reference":[{"key":"3864_CR1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2147\/OPTH.S38415","volume":"6","author":"LA Lim","year":"2013","unstructured":"Lim LA, Madigan MC, Conway RM (2013) Conjunctival melanoma: a review of conceptual and treatment advances. Clin Ophthalmol 6:521\u2013531","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"3864_CR2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1586\/17469899.2014.921119","volume":"9","author":"JR Wong","year":"2014","unstructured":"Wong JR, Nanji AA, Galor A, Karp CL (2014) Management of conjunctival malignant melanoma: a review and update. Expert Rev Ophthalmol 9(3):185\u2013204","journal-title":"Expert Rev Ophthalmol"},{"issue":"2","key":"3864_CR3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.sjopt.2012.02.004","volume":"26","author":"BE Damato","year":"2012","unstructured":"Damato BE, Coupland SE (2012) Ocular melanoma. Saudi J Ophthalmol 26(2):137\u2013144","journal-title":"Saudi J Ophthalmol"},{"issue":"1","key":"3864_CR4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/1066896908319775","volume":"18","author":"GA Novais","year":"2010","unstructured":"Novais GA, Fernandes BF, Belfort RN, Castiglione E, Cheema DP, Burnier MN Jr (2010) Incidence of melanocytic lesions of the conjunctiva in a review of 10,675 ophthalmic specimens. Int J Surg Pathol 18(1):60\u201363","journal-title":"Int J Surg Pathol"},{"key":"3864_CR5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/107327481602300205","volume":"23","author":"A Kao","year":"2016","unstructured":"Kao A, Afshar A, Bloomer M, Damato B (2016) Management of primary acquired melanosis, nevus, and conjunctival melanoma. Cancer Control 23:117\u2013125","journal-title":"Cancer Control"},{"issue":"12","key":"3864_CR6","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.5858\/2009-0522-RAR.1","volume":"134","author":"A Zembowicz","year":"2010","unstructured":"Zembowicz A, Mandal RV, Choopong P (2010) Melanocytic lesions of the conjunctiva. Arch Pathol Lab Med 134(12):1785\u20131792","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"3864_CR7","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1586\/era.09.85","volume":"9","author":"B Damato","year":"2009","unstructured":"Damato B, Coupland SE (2009) Management of conjunctival melanoma. Expert Rev Anticancer Ther 9(9):1227\u20131239","journal-title":"Expert Rev Anticancer Ther"},{"issue":"5","key":"3864_CR8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/ICU.0b013e32833b7aab","volume":"21","author":"Y Shildkrot","year":"2010","unstructured":"Shildkrot Y, Wilson MW (2010) Conjunctival melanoma: pitfalls and dilemmas in management. Curr Opin Ophthalmol 21(5):380\u2013386","journal-title":"Curr Opin Ophthalmol"},{"issue":"1","key":"3864_CR9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1600-0560.2010.01625.x","volume":"38","author":"A Savar","year":"2011","unstructured":"Savar A, Esmaeli B, Ho H, Liu S, Prieto VG (2011) Conjunctival melanoma: local-regional control rates, and impact of high-risk histopathologic features. J Cutan Pathol 38(1):18\u201324","journal-title":"J Cutan Pathol"},{"issue":"1","key":"3864_CR10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1167\/iovs.04-0344","volume":"46","author":"GS Missotten","year":"2005","unstructured":"Missotten GS, Keijser S, De Keizer RJ, De Wolff-Rouendaal D (2005) Conjunctival melanoma in the Netherlands: a nationwide study. Invest Ophthalmol Vis Sci 46(1):75\u201382","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3864_CR11","first-page":"64","volume":"110","author":"B Esmaeli","year":"2012","unstructured":"Esmaeli B, Roberts D, Ross M et al (2012) Histologic features of conjunctival melanoma predictive of metastasis and death (an American ophthalmological thesis). Trans Am Ophthalmol Soc 110:64\u201373","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"7","key":"3864_CR12","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/bjophthalmol-2014-305730","volume":"99","author":"X Sheng","year":"2015","unstructured":"Sheng X, Li S, Chi Z, Si L, Cui C, Mao L et al (2015) Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patients. Br J Ophthalmol 99(7):990\u2013996","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"3864_CR13","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.ophtha.2011.05.025","volume":"118","author":"LM Heindl","year":"2011","unstructured":"Heindl LM, Hofmann-Rummelt C, Adler W, Bosch JJ, Holbach LM, Naumann GO et al (2011) Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva. Ophthalmology 118(12):2351\u20132360","journal-title":"Ophthalmology"},{"issue":"2","key":"3864_CR14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/eye.2012.254","volume":"27","author":"N Kenawy","year":"2013","unstructured":"Kenawy N, Lake SL, Coupland SE, Damato BE (2013) Conjunctival melanoma and melanocytic intra-epithelial neoplasia. Eye (Lond). 27(2):142\u2013152","journal-title":"Eye (Lond)."},{"issue":"8","key":"3864_CR15","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1167\/iovs.10-6934","volume":"52","author":"SL Lake","year":"2011","unstructured":"Lake SL, Jmor F, Dopierala J, Taktak AF, Coupland SE, Damato BE (2011) Multiplex ligation-dependent probe amplification of conjunctival melanoma reveals common BRAF V600E gene mutation and gene copy number changes. Invest Ophthalmol Vis Sci 52(8):5598\u20135604","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"3864_CR16","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1158\/1078-0432.CCR-13-0163","volume":"19","author":"KG Griewank","year":"2013","unstructured":"Griewank KG, Westekemper H, Murali R, Mach M, Schilling B, Wiesner T et al (2013) Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas. Clin Cancer Res 19(12):3143\u20133152","journal-title":"Clin Cancer Res"},{"issue":"5","key":"3864_CR17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/aos.13007","volume":"94","author":"AC Larsen","year":"2016","unstructured":"Larsen AC, Dahl C, Dahmcke CM, Lade-Keller J, Siersma VD, Toft PB et al (2016) BRAF mutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions. Acta Ophthalmol 94(5):463\u2013470","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"3864_CR18","first-page":"29","volume":"30","author":"ES Blum","year":"2016","unstructured":"Blum ES, Yang J, Komatsubara KM et al (2016) Clinical management of uveal and conjunctival melanoma. Oncology 30(1):29\u201332 34\u201343, 48","journal-title":"Oncology"},{"issue":"3","key":"3864_CR19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/CMR.0b013e3280dec6ac","volume":"17","author":"BW Chwirot","year":"2007","unstructured":"Chwirot BW, Ku\u017abicki \u0141 (2007) Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours. Melanoma Res 17(3):139\u2013145","journal-title":"Melanoma Res"},{"issue":"5","key":"3864_CR20","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0008-4182(03)80045-5","volume":"38","author":"A Figueiredo","year":"2003","unstructured":"Figueiredo A, Caissie AL, Callejo SA, McLean IW, Gold P, Burnier MN Jr (2003) Cyclooxygenase-2 expression in uveal melanoma: novel classification of mixed-cell-type tumours. Can J Ophthalmol 38(5):352\u2013356","journal-title":"Can J Ophthalmol"},{"key":"3864_CR21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-3163-6-17","volume":"6","author":"JC Marshall","year":"2007","unstructured":"Marshall JC, Caissie AL, Cruess SR, Cools-Lartigue J, Burnier MN Jr (2007) The effects of a cyclooxygenase-2 (COX-2) expression and inhibition on human uveal melanoma cell proliferation and macrophage nitric oxide production. J Carcinog 6:17","journal-title":"J Carcinog"},{"key":"3864_CR22","first-page":"539","volume-title":"American Joint Committee on Cancer staging manual","author":"SB Edge","year":"2010","unstructured":"Edge SB (2010) Malignant melanoma of the conjunctiva. In: Edge SB, Byrd DR, Compton CC et al (eds) American Joint Committee on Cancer staging manual, 7th edn. Springer, New York, pp 539\u2013546","edition":"7"},{"issue":"8","key":"3864_CR23","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0344-0338(11)81095-2","volume":"189","author":"W Remmele","year":"1993","unstructured":"Remmele W, Schicketanz KH (1993) Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS). Pathol Res Pract 189(8):862\u2013866","journal-title":"Pathol Res Pract"},{"issue":"9","key":"3864_CR24","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1002\/cncr.24999","volume":"116","author":"D Mougiakakos","year":"2010","unstructured":"Mougiakakos D, Johansson CC, Trocme E, All-Ericsson C, Economou MA, Larsson O et al (2010) Intratumoral forkhead box P3-positive regulatory T cells predict poor survival in cyclooxygenase-2-positive uveal melanoma. Cancer 116(9):2224\u20132233","journal-title":"Cancer"},{"issue":"5","key":"3864_CR25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/IOP.0b013e3182611670","volume":"28","author":"CL Shields","year":"2012","unstructured":"Shields CL, Kaliki S, Al-Dahmash SA, Lally SE, Shields JA (2012) American Joint Committee on Cancer (AJCC) clinical classification predicts conjunctival melanoma outcomes. Ophthal Plast Reconstr Surg 28(5):313\u2013323","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"5","key":"3864_CR26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/archophthalmol.2011.2566","volume":"130","author":"YA Yousef","year":"2012","unstructured":"Yousef YA, Finger PT (2012) Predictive value of the seventh edition American Joint Committee on Cancer staging system for conjunctival melanoma. Arch Ophthalmol 130(5):599\u2013606","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"3864_CR27","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1442-9071.2008.01888.x","volume":"36","author":"B Damato","year":"2008","unstructured":"Damato B, Coupland SE (2008) Conjunctival melanoma and melanosis: a reappraisal of terminology, classification and staging. Clin Exp Ophthalmol 36(8):786\u2013795","journal-title":"Clin Exp Ophthalmol"},{"issue":"11","key":"3864_CR28","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/bjo.2007.129882","volume":"92","author":"B Damato","year":"2008","unstructured":"Damato B, Coupland SE (2008) Clinical mapping of conjunctival melanomas. Br J Ophthalmol 92(11):1545\u20131549","journal-title":"Br J Ophthalmol"},{"key":"3864_CR29","first-page":"471","volume":"98","author":"CL Shields","year":"2000","unstructured":"Shields CL (2000) Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Trans Am Ophthalmol Soc 98:471\u2013492","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"2","key":"3864_CR30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ophtha.2010.06.021","volume":"118","author":"CL Shields","year":"2011","unstructured":"Shields CL, Markowitz JS, Belinsky I, Schwartzstein H, George NS, Lally SE et al (2011) Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases. Ophthalmology 118(2):389\u2013395","journal-title":"Ophthalmology"},{"issue":"11","key":"3864_CR31","first-page":"3399","volume":"43","author":"S Tuomaala","year":"2002","unstructured":"Tuomaala S, Eskelin S, Tarkkanen A, Kivel\u00e4 T (2002) Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Invest Ophthalmol Vis Sci 43(11):3399\u20133408","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3864_CR32","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1001\/archopht.1980.01020040230003","volume":"98","author":"FA Jakobiec","year":"1980","unstructured":"Jakobiec FA (1980) Conjunctival melanoma. Arch Ophthalmol 98:1378\u20131384","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"3864_CR33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/eye.2012.256","volume":"27","author":"T Kivel\u00e4","year":"2013","unstructured":"Kivel\u00e4 T, Kujala E (2013) Prognostication in eye cancer: the latest tumor, node, metastasis classification and beyond. Eye (Lond) 27(2):243\u2013252","journal-title":"Eye (Lond)"},{"issue":"2","key":"3864_CR34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.86.2.163","volume":"86","author":"G Anastassiou","year":"2002","unstructured":"Anastassiou G, Heiligenhaus A, Bechrakis N, Bader E, Bornfeld N, Steuhl KP (2002) Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study. Br J Ophthalmol 86(2):163\u2013167","journal-title":"Br J Ophthalmol"},{"key":"3864_CR35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1755-3768.1992.tb08566.x","volume":"70","author":"S Seregard","year":"1992","unstructured":"Seregard S, Kock E (1992) Conjunctival malignant melanoma in Sweden 1969\u201391. Acta Ophthalmol 70:289\u2013296","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"3864_CR36","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/bjo.78.7.520","volume":"78","author":"AD Paridaens","year":"1994","unstructured":"Paridaens AD, McCartney AC, Minassian DC, Hungerford JL (1994) Orbital exenteration in 95 cases of primary conjunctival malignant melanoma. Br J Ophthalmol 78(7):520\u2013528","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"3864_CR37","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1093\/carcin\/bgm091","volume":"28","author":"JC Marshall","year":"2007","unstructured":"Marshall JC, Fernandes BF, Di Cesare S, Maloney SC, Logan PT, Antecka E, Burnier MN Jr (2007) The use of a cyclooxygenase-2 inhibitor (Nepafenac) in an ocular and metastatic animal model of uveal melanoma. Carcinogenesis 28(9):2053\u20132058","journal-title":"Carcinogenesis"},{"issue":"5","key":"3864_CR38","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/CMR.0000000000000282","volume":"26","author":"\u0141 Ku\u017abicki","year":"2016","unstructured":"Ku\u017abicki \u0141, Chwirot BW (2016) Intratumoral expression of cyclooxygenase-2 (COX-2) is a negative prognostic marker for patients with cutaneous melanoma. Melanoma Res 26(5):448\u2013456","journal-title":"Melanoma Res"},{"issue":"1","key":"3864_CR39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ijc.25976","volume":"130","author":"C Muraki","year":"2012","unstructured":"Muraki C, Ohga N, Hida Y, Nishihara H, Kato Y, Tsuchiya K et al (2012) Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells. Int J Cancer 130(1):59\u201370","journal-title":"Int J Cancer"},{"key":"3864_CR40","unstructured":"Caissie A (2004) Cyclooxygenase-2 and other targets of adjuvant therapies for uveal melanoma. http:\/\/digitool.Library.McGill.CA:80\/R\/-?func=dbin-jump-full&object_id=85893&silo_library=GEN01 . Accessed 2 May 2017"},{"issue":"2","key":"3864_CR41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/02713680701867908","volume":"33","author":"LM Cryan","year":"2008","unstructured":"Cryan LM, Paraoan L, Hiscott P, Damato BE, Grierson I, Gray D et al (2008) Expression of COX-2 and prognostic outcome in uveal melanoma. Curr Eye Res 33(2):177\u2013184","journal-title":"Curr Eye Res"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-017-3864-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-017-3864-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-017-3864-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T07:07:13Z","timestamp":1719731233000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-017-3864-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,2]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["3864"],"URL":"https:\/\/doi.org\/10.1007\/s00417-017-3864-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"type":"print","value":"0721-832X"},{"type":"electronic","value":"1435-702X"}],"subject":[],"published":{"date-parts":[[2018,1,2]]}}}